|
HNRNPC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.620200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.998400E-04 |
| Normal-vs-Stage2 |
3.563200E-01 |
| Normal-vs-Stage3 |
1.371400E-01 |
| Normal-vs-Stage4 |
5.757900E-04 |
| Stage1-vs-Stage2 |
1.822350E-03 |
| Stage1-vs-Stage3 |
1.297590E-01 |
| Stage1-vs-Stage4 |
3.299600E-01 |
| Stage2-vs-Stage3 |
4.387500E-02 |
| Stage2-vs-Stage4 |
5.638200E-04 |
| Stage3-vs-Stage4 |
3.197700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.059660E-03 |
| Normal-vs-AfricanAmerican |
1.158040E-02 |
| Normal-vs-Asian |
2.672400E-02 |
| Caucasian-vs-AfricanAmerican |
2.192200E-01 |
| Caucasian-vs-Asian |
7.789200E-01 |
| AfricanAmerican-vs-Asian |
2.160400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.185700E-02 |
| Normal-vs-Female |
2.103000E-03 |
| Male-vs-Female |
5.146200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.957200E-04 |
| Normal-vs-Age(41-60Yrs) |
4.171600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.347200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.052400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.685800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.458100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.540400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.347000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.924000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.447200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.020200E-01 |
| Classical-VS-Follicular |
2.03259999942418E-08 |
| Classical-VS-Other |
7.411800E-01 |
| Classical-VS-Normal |
2.90120000001615E-06 |
| Tall-VS-Follicular |
1.022990E-03 |
| Tall-VS-Other |
5.566600E-01 |
| Tall-VS-Normal |
2.747800E-02 |
| Follicular-VS-Other |
3.328200E-02 |
| Follicular-VS-Normal |
7.238400E-02 |
| Other-VS-Normal |
2.172000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.323600E-01 |
| Normal-vs-N1 |
3.473900E-02 |
| N0-vs-N1 |
1.144610E-01 |
|
|
